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697Abstracts
OBJECTIVE: Chronic skin diseases have a heavy impact
on the physical and mental well-being of the patient. 
This is conﬁrmed by the large number of quality of life
studies that exist. Paradoxically, no study has evaluated
depressive symptomatology in Spanish patients with 
dermatosis. This was why it was decided to carry out, in
association with Accion Psoriasis (a Spanish Patient
Support Group), an evaluation of the depressive symp-
tomatology of patients suffering from psoriasis.
METHODS: The CES-D scale (Center for Epidemiologic
Studies—Depression scale) was developed in the USA at
the National Institute of Mental Health to perform epi-
demiological studies of depressive symptomatology in the
general population. The CES-D scale was sent to 1300
patients with psoriasis, members or supporters of Accion
Psoriasis. The completed questionnaires were returned in
prepaid envelopes. RESULTS: Out of the 1300 question-
naires sent out in March 2003. At mid-March 2003, 300
questionnaires were returned: response rate 23%. The
presented results concerned the 106 ﬁrst questionnaires
analysed. The male/female gender ratio was as follows
54/46. Depressive symptomatology was observed in 
44% of men (average score 17.8) and 55% of women
(average score 21). This difference between men and
women was not statistically signiﬁcant. An evaluation
according to the age at diagnosis was also carried out: 2
groups were identiﬁed: diagnosis at 16 years of age or
younger versus a group diagnosed after the age of 16.
Depressive symptomatology was observed in 54% of
patients in the ﬁrst group versus 46% of patients in the
second group. CONCLUSION: These preliminary results
show the importance of the psychological impact of 
dermatosis, especially psoriasis. Global management of
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OBJECTIVE: Chronic skin diseases have a heavy impact
on the physical and mental well-being of the patient. This
is conﬁrmed by the large number of quality of life studies
that exist. Paradoxically, no study has evaluated depres-
sive symptomatology in Italian patients with dermatosis.
This was why it was decided to carry out, in association
with ADIPSO (an Italian Patient Support Group), an eval-
uation of the depressive symptomatology of patients suf-
fering from psoriasis. Tools: the CES-D scale (Center for
Epidemiologic Studies—Depression scale) was developed
in the USA at the National Institute Of Mental Health to
perform epidemiological studies of depressive symptoma-
tology in the general population. METHOD: The CES-D
scale was remitted by Italian Dermatologists to the ﬁrst
5000 patients with psoriasis coming to their ofﬁce. The
completed questionnaires were returned in prepaid
envelopes. RESULTS: Out of the 5000 questionnaires
remitted in February and March 2003. At mid-March
2003, 3000 questionnaires were returned: response rate
60%. The presented results concerned the 100 ﬁrst ques-
tionnaires analysed. The male/female gender ratio was as
follows 61/39. Depressive symptomatology was observed
in 34% of men (average score 17.2) and 62% of women
(average score 21). This difference between men and
women was statistically signiﬁcant (p = 0.007). An eval-
uation according to the education level was also carried
out: Two groups were identiﬁed: patients having a
primary/secondary education level (n = 69) versus pa-
tients having a higher education level (n = 31). Depres-
sive symptomatology was observed in 51% of patients in
the ﬁrst group versus 32% of patients in the second
group. This difference according to the education level
was statistically signiﬁcant (p < 0.02). CONCLUSION:
These preliminary results show the importance of the 
psychological impact of dermatosis, especially psoriasis.
Global management of patients seems essential for
patients suffering from chronic dermatosis.
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OBJECTIVES: Attention deﬁcit/hyperactivity disorder
(ADHD) is a behavioral disorder, originating in child-
hood, with broad impairment in academic performance,
social functioning, and quality of life. ADHD health state
utilities have not previously been assessed using parent
ratings. Health state utilities are needed to calculate
quality-adjusted life years (QALYs), a critical measure of
outcomes in cost-effectiveness studies. The purpose of this
study was to use standard gamble (SG) utility methodol-
ogy to assess parent preferences for ADHD health states.
METHODS: Parents of children diagnosed with ADHD
completed SG utility interviews, in which they rated their
child’s current health and 11 hypothetical health states
(e.g., untreated ADHD; stimulant treatment; atomoxetine
treatment, a new non-stimulant). The hypothetical health
states were developed based on physician interviews, pub-
lished literature, and unpublished clinical trial data.
Parents reported children’s symptoms using the 18-item
ADHD-RS. Construct validity and health state differences
were examined with correlations, t-tests, and ANOVAs.
RESULTS: Participants were 43 parents of children with
ADHD. The mean parent SG rating of their child’s
